Brief: Huakang Biomedical Sees Loss Attributable Of Not More Than RMB5.8 Mln For FY
25/03/2024 14:11
March 25 (Reuters) - Huakang Biomedical Holdings Co Ltd
8622.HK :
* HUAKANG BIOMEDICAL SEES LOSS ATTRIBUTABLE OF NOT MORE
THAN
RMB5.8 MILLION FOR FY
* HUAKANG BIOMEDICAL SEES DECREASE IN GROUP'S GROSS PROFIT
FOR
CURRENT YEAR
Further company coverage: 8622.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joyzyme
See all newsChairman
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology